Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Bevacizumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 101 Breast Neoplasms 78 Carcinoma, Non-Small-Cell Lung 74 Glioblastoma 64 Ovarian Neoplasms 53 Brain Neoplasms 42 Glioma 38 Neoplasms 36 Fallopian Tube Neoplasms 35 Lung Neoplasms 32 Gliosarcoma 31 Colonic Neoplasms 29 Carcinoma, Renal Cell 29 Rectal Neoplasms 28 Neoplasm Metastasis 27 Pancreatic Neoplasms 19 Adenocarcinoma of Lung 17 Carcinoma, Hepatocellular 16 Melanoma 15 Astrocytoma 14 Stomach Neoplasms 12 Kidney Neoplasms 12 Uterine Cervical Neoplasms 11 Oligodendroglioma 11 Esophageal Neoplasms 11 Liver Neoplasms 10 Central Nervous System Neoplasms 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Sarcoma 8 Recurrence 8

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡